AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,364,001 | -64.6% | 62,441 | -63.6% | 0.00% | -66.7% |
Q2 2023 | $12,329,163 | +230.2% | 171,572 | +183.5% | 0.00% | +200.0% |
Q1 2023 | $3,733,305 | -65.3% | 60,527 | -56.6% | 0.00% | -66.7% |
Q4 2022 | $10,756,472 | +40.9% | 139,459 | -18.5% | 0.00% | +50.0% |
Q3 2022 | $7,632,000 | +1527.3% | 171,050 | +1298.7% | 0.00% | – |
Q2 2022 | $469,000 | -9.1% | 12,229 | -1.9% | 0.00% | – |
Q1 2022 | $516,000 | +10.0% | 12,469 | +0.5% | 0.00% | – |
Q4 2021 | $469,000 | +4.7% | 12,413 | -8.8% | 0.00% | – |
Q3 2021 | $448,000 | -96.0% | 13,605 | -91.7% | 0.00% | -100.0% |
Q2 2021 | $11,089,000 | +48.2% | 164,383 | +24.4% | 0.00% | +50.0% |
Q1 2021 | $7,481,000 | -77.0% | 132,133 | -66.9% | 0.00% | -77.8% |
Q4 2020 | $32,514,000 | +6.8% | 399,092 | -6.6% | 0.01% | -10.0% |
Q3 2020 | $30,458,000 | -25.8% | 427,488 | -14.3% | 0.01% | -33.3% |
Q2 2020 | $41,028,000 | +6.0% | 498,639 | -24.2% | 0.02% | -6.2% |
Q1 2020 | $38,723,000 | -38.7% | 658,222 | +7.7% | 0.02% | -20.0% |
Q4 2019 | $63,190,000 | +228.9% | 611,359 | -35.6% | 0.02% | +300.0% |
Q3 2019 | $19,214,000 | -7.6% | 949,305 | +17.6% | 0.01% | 0.0% |
Q2 2019 | $20,793,000 | +39.1% | 807,509 | -23.1% | 0.01% | 0.0% |
Q1 2019 | $14,948,000 | – | 1,050,478 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |